Tuesday, May 8, 2007

Sciele Pharma to offer $250 mln of convertible senior notes

(Reuters) - The remainder of the proceeds will be used for future acquisitions or licenses of products and technologies and for capital expenditures and general corporate purposes.




Read more at Reuters.com Government Filings News

No comments: